CLC channel function and dysfunction in health and disease
- PMID: 25339907
- PMCID: PMC4188032
- DOI: 10.3389/fphys.2014.00378
CLC channel function and dysfunction in health and disease
Abstract
CLC channels and transporters are expressed in most tissues and fulfill diverse functions. There are four human CLC channels, ClC-1, ClC-2, ClC-Ka, and ClC-Kb, and five CLC transporters, ClC-3 through -7. Some of the CLC channels additionally associate with accessory subunits. Whereas barttin is mandatory for the functional expression of ClC-K, GlialCam is a facultative subunit of ClC-2 which modifies gating and thus increases the functional variability within the CLC family. Isoform-specific ion conduction and gating properties optimize distinct CLC channels for their cellular tasks. ClC-1 preferentially conducts at negative voltages, and the resulting inward rectification provides a large resting chloride conductance without interference with the muscle action potential. Exclusive opening at voltages negative to the chloride reversal potential allows for ClC-2 to regulate intracellular chloride concentrations. ClC-Ka and ClC-Kb are equally suited for inward and outward currents to support transcellular chloride fluxes. Every human CLC channel gene has been linked to a genetic disease, and studying these mutations has provided much information about the physiological roles and the molecular basis of CLC channel function. Mutations in the gene encoding ClC-1 cause myotonia congenita, a disease characterized by sarcolemmal hyperexcitability and muscle stiffness. Loss-of-function of ClC-Kb/barttin channels impairs NaCl resorption in the limb of Henle and causes hyponatriaemia, hypovolemia and hypotension in patients suffering from Bartter syndrome. Mutations in CLCN2 were found in patients with CNS disorders but the functional role of this isoform is still not understood. Recent links between ClC-1 and epilepsy and ClC-Ka and heart failure suggested novel cellular functions of these proteins. This review aims to survey the knowledge about physiological and pathophysiological functions of human CLC channels in the light of recent discoveries from biophysical, physiological, and genetic studies.
Keywords: Bartter syndrome; CLC channel; anion channel; leukencephalopathy; myotonia congenita; patch clamp.
Figures






Similar articles
-
Carboxyl-terminal Truncations of ClC-Kb Abolish Channel Activation by Barttin Via Modified Common Gating and Trafficking.J Biol Chem. 2015 Dec 18;290(51):30406-16. doi: 10.1074/jbc.M115.675827. Epub 2015 Oct 9. J Biol Chem. 2015. PMID: 26453302 Free PMC article.
-
Activation of renal ClC-K chloride channels depends on an intact N terminus of their accessory subunit barttin.J Biol Chem. 2018 Jun 1;293(22):8626-8637. doi: 10.1074/jbc.RA117.000860. Epub 2018 Apr 19. J Biol Chem. 2018. PMID: 29674316 Free PMC article.
-
Physiology and pathophysiology of ClC-K/barttin channels.Front Physiol. 2010 Nov 26;1:155. doi: 10.3389/fphys.2010.00155. eCollection 2010. Front Physiol. 2010. PMID: 21423394 Free PMC article.
-
ClC-K chloride channels: emerging pathophysiology of Bartter syndrome type 3.Am J Physiol Renal Physiol. 2015 Jun 15;308(12):F1324-34. doi: 10.1152/ajprenal.00004.2015. Epub 2015 Mar 25. Am J Physiol Renal Physiol. 2015. PMID: 25810436 Review.
-
Defective Gating and Proteostasis of Human ClC-1 Chloride Channel: Molecular Pathophysiology of Myotonia Congenita.Front Neurol. 2020 Feb 11;11:76. doi: 10.3389/fneur.2020.00076. eCollection 2020. Front Neurol. 2020. PMID: 32117034 Free PMC article. Review.
Cited by
-
Pathological role of ion channels and transporters in the development and progression of triple-negative breast cancer.Cancer Cell Int. 2020 Aug 6;20:377. doi: 10.1186/s12935-020-01464-9. eCollection 2020. Cancer Cell Int. 2020. PMID: 32782435 Free PMC article. Review.
-
ClC-2-like Chloride Current Alterations in a Cell Model of Spinal and Bulbar Muscular Atrophy, a Polyglutamine Disease.J Mol Neurosci. 2021 Mar;71(3):662-674. doi: 10.1007/s12031-020-01687-5. Epub 2020 Aug 28. J Mol Neurosci. 2021. PMID: 32856205
-
Charting a TRP to Novel Therapeutic Destinations for Kidney Diseases.Trends Pharmacol Sci. 2019 Dec;40(12):911-918. doi: 10.1016/j.tips.2019.10.001. Epub 2019 Nov 5. Trends Pharmacol Sci. 2019. PMID: 31704171 Free PMC article. Review.
-
Myotonia congenita and periodic hypokalemia paralysis in a consanguineous marriage pedigree: Coexistence of a novel CLCN1 mutation and an SCN4A mutation.PLoS One. 2020 May 14;15(5):e0233017. doi: 10.1371/journal.pone.0233017. eCollection 2020. PLoS One. 2020. PMID: 32407401 Free PMC article.
-
ClC-3: biophysical properties clarify cellular functions.J Physiol. 2018 Sep;596(17):3823-3824. doi: 10.1113/JP276670. Epub 2018 Jul 29. J Physiol. 2018. PMID: 29974478 Free PMC article. No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical